Spyre Therapeutics, Inc.
Latest Stock Split
Sep 08, 2023
1:25
For every 25 shares held, investors received 1.
The split itself did not change the total investment value.
Use this split data in your app
Build with our dataStock Split History
- Sep 08, 2023Before—Split ratio1:25After—Reverse
About Spyre Therapeutics, Inc. stock splits
Spyre Therapeutics, Inc. (GETTEX:3920) operates in the Pharmaceuticals: major industry.
Spyre Therapeutics, Inc. company overviewWhen did Spyre Therapeutics, Inc. stock split?
Spyre Therapeutics, Inc.'s most recent stock split was on September 8, 2023. It was a 1-for-25 reverse split, so shareholders received 1 share for every 25 they held.
How many times has Spyre Therapeutics, Inc. stock split?
Spyre Therapeutics, Inc. has split its stock once. This history records one reverse split, on September 8, 2023.
What is a reverse stock split?
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Spyre Therapeutics, Inc.'s 1-for-25 reverse split on September 8, 2023, every 25 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Will Spyre Therapeutics, Inc. split its stock again?
Spyre Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on September 8, 2023, 3 years ago. Companies announce splits in advance, and any new GETTEX:3920 split will appear on this page.